IFM Management, Inc.
Records under this name other than patents IFM Management, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,654,816 | Compounds and Compositions for Treating Conditions Associated with NLRP Activity conveyed to Novartis Inflammasome Research Inc. - now held by Novartis AG In force · Medium confidence | In force | Medium confidence | |
| US 11,203,579 | Compounds and Compositions for Treating Conditions Associated with NLRP Activity conveyed to Novartis Inflammasome Research Inc. - now held by Novartis AG In force · High confidence | In force | High confidence | |
| US 11,724,992 | Compounds and Compositions for Treating Conditions Associated with NLRP Activity conveyed to Novartis Inflammasome Research Inc. - now held by Novartis AG In force · High confidence | In force | High confidence | |
| US 12,084,424 | Compounds and Compositions for Treating Conditions Associated with NLRP Activity conveyed to Novartis Inflammasome Research Inc. - now held by Novartis AG In force · Medium confidence | In force | Medium confidence | |
| US 11,370,763 | Compounds and Compositions for Treating Conditions Associated with NLRP Activity conveyed to Novartis Inflammasome Research Inc. - now held by Novartis AG In force · High confidence | In force | High confidence | |
| US 11,718,631 | Sulphonamides and Compositions Thereof for Treating Conditions Associated with NLRP Activity conveyed to Novartis Inflammasome Research Inc. - now held by Novartis AG In force · High confidence | In force | High confidence | |
| US 11,618,749 | Compounds and Compositions for Treating Conditions Associated with Sting Activity conveyed to IFM Due Inc. - now held by Novartis Pharma AG In force · High confidence | In force | High confidence | |
| US 12,134,611 | Compounds and Compositions for Treating Conditions Associated with NLRP Activity conveyed to Novartis Inflammasome Research Inc. - now held by Novartis AG In force · High confidence | In force | High confidence | |
| US 12,152,018 | Compounds and Compositions for Treating Conditions Associated with Sting Activity conveyed to IFM Due Inc. - now held by Novartis Pharma AG In force · High confidence | In force | High confidence | |
| US 12,503,436 | Compounds and Compositions for Treating Conditions Associated with Sting Activity conveyed to IFM Due Inc. - now held by Novartis Pharma AG In force · High confidence | In force | High confidence |